PDS Biotech announces annual shareholder meeting webcast

• PDS Biotechnology will hold its annual shareholder meeting virtually on Aug. 10, 2026.
• Shareholders will vote to elect two Class B directors: Kamil Ali-Jackson and Ilian Iliev.
• The meeting will also consider a charter amendment to raise authorized common stock to 300,000,000 shares from 150,000,000.
• Other items include ratifying KPMG as auditor for fiscal 2026 and an advisory vote on named executive officer pay.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PDS Biotechnology Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-025211), on June 15, 2026, and is solely responsible for the information contained therein.